Engineering Illustrations of Correcting Building Inclination by Stress Redistribution Method

By drilling large diameter holes in foundation soil and digging out soils to release (or redistribute) lateral stress in subsoil so as to create new settlement, a new method, which is called stress redistribution method, has been developed for correcting inclined building on soft foundation soil. Using this method, tens buildings with inclination up to 1-2% have been corrected and resumed their normal function in Wuhan, China. Some typical case histories are selected to illustrate the sensitive, controllable, and reliable characteristics of this method. The technical problems encountered in correcting process, such as the induced settlement, its influence on neighbour building, the digging scheme adopted, etc., are analysed. Two operating procedure have been summarized based on the practice of correcting. Lastly, the possibility of correcting the inclination of the tower of Pisa is discussed

Polymer-protein conjugate particles with biocatalytic activity for stabilization of water-in-water emulsions

Water-in-water (w/w) emulsions are attractive micro-compartmentalized platforms due to their outstanding biocom-patibility. To address the main disadvantage of poor stability that hampers their practical application, here we report a novel type of polymer-protein conjugate emulsifier obtained by Schiff base synthesis to stabilize w/w emulsions. In par-ticular, the proposed mild approach benefits the modification of proteins of suitable size and wettability as particulate emulsifiers retaining their bioactivity. As demonstrated in a model system, the methoxy polyethylene glycol (mPEG)-urease conjugate particles anchor at the w/w interfaces, where they serve as an effective emulsifier-combined-catalyst and catalyze the hydrolysis of urea in water to ammonium carbonate. Our study is unique in that it employs bioactive particles to stabilize w/w emulsions. Considering the characteristics of all-aqueous, compartmental and interfacial bio-catalysis of the system, it will open up new possibilities in the life sciences

Dietary inclusion of fermented ginger straw effect on the growth performance, gastrointestinal tract development and caecal fermentation of fattening rabbits

[EN] This experiment was conducted to evaluate the effects of dietary inclusion of fermented ginger straw on the growth performance, gastrointestinal tract development and caecal fermentation of fattening rabbits. A total of 160 45-d-old Laiwu black rabbits were randomly divided into 4 groups and fed 0% (Control), 5, 10 or 15% fermented ginger straw in their diet as a replacement for peanut straw powder. The trial lasted for 7 d of adaptation and 43 d for testing. Growth performance was recorded from 52 to 95 d of age (n=5 per treatment with 30 rabbits, 3 males and 3 females per replicate), TTAD of nutrients from 91 to 95 d of age, and gastrointestinal tract development, caecum fermentation and carcass traits were determined at 95 d of age (n=5 per treatment with 10 rabbits, 1 males and 1 females in per replicate).The results showed that the average daily gain and final body weight in the experimental groups (5, 10 and 15% fermented ginger straw) were higher than in the control group (P<0.05). However, the average daily feed intake in the 15% group was higher than in the other groups, while the total tract apparent digestibility of crude protein, ether extract, neutral detergent fibre and acid detergent fibre were lower than in the control group (P<0.05), and the relative weights of the stomach, small intestine and caecum content in the 15% substitution group were higher than those in the control group (P<0.05). In addition, the thickness of the muscle layer in the 15% substitution group was higher than that in the other groups (P<0.05). Moreover, pH and total volatile fatty acids concentration in the caecal content were similar among the 4 groups (P>0.05). The current work shows that fermented ginger straw could be used as roughage material in fattening rabbit production up to a dietary dose of 10%.This study was supported by Earmarked Fund for Modern Agro-industry Technology Research System (CARS-43-G-7); Shandong Province Modern Agricultural Industry Technology System (SDAIT-21); Scientific and Technological Problems Project Unveiled by Shandong Academy of Agricultural Sciences (SHJB2021-43).Sun, HT.; Wang, Y.; Bai, LY.; Liu, C.; Xu, YH.; Gao, SX.; Jiang, WX.... (2022). Dietary inclusion of fermented ginger straw effect on the growth performance, gastrointestinal tract development and caecal fermentation of fattening rabbits. World Rabbit Science. 30(4):267-276. https://doi.org/10.4995/wrs.2022.1609326727630

Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology

CAR-T cell therapy, a novel immunotherapy, has made significant breakthroughs in clinical practice, particularly in treating B-cell-associated leukemia and lymphoma. However, it still faces challenges such as poor persistence, limited proliferation capacity, high manufacturing costs, and suboptimal efficacy. CRISPR/Cas system, an efficient and simple method for precise gene editing, offers new possibilities for optimizing CAR-T cells. It can increase the function of CAR-T cells and reduce manufacturing costs. The combination of CRISPR/Cas9 technology and CAR-T cell therapy may promote the development of this therapy and provide more effective and personalized treatment for cancer patients. Meanwhile, the safety issues surrounding the application of this technology in CAR-T cells require further research and evaluation. Future research should focus on improving the accuracy and safety of CRISPR/Cas9 technology to facilitate the better development and application of CAR-T cell therapy. This review focuses on the application of CRISPR/Cas9 technology in CAR-T cell therapy, including eliminating the inhibitory effect of immune checkpoints, enhancing the ability of CAR-T cells to resist exhaustion, assisting in the construction of universal CAR-T cells, reducing the manufacturing costs of CAR-T cells, and the security problems faced. The objective is to show the revolutionary role of CRISPR/Cas9 technology in CAR-T cell therapy for researchers

Final State Interactions in D0→K0K0ˉD^0 \to K^0 \bar{K^0}

It is believed that the production rate of $D^0\to K^0\bar K^0$ is almost solely determined by final state interactions (FSI) and hence provides an ideal place to test FSI models. Here we examine model calculations of the contributions from s-channel resonance $f_J(1710)$ and t-channel exchange to the FSI effects in $D^0\to K^0\bar K^0$. The contribution from s-channel $f_0(1710)$ is sma$For the t-channel FSI evaluation, we employ the one-particle-exchange (OPE) model and Regge model respecti$ The results from two methods are roughly consistent with each other and can reproduce the large rate of $D^0\to K^0\bar K^0$ reasonably well$Comment: Latex, 16 pages, with 2 figure

FGF21 ameliorates the neurocontrol of blood pressure in the high fructose-drinking rats

Fibroblast growth factor-21 (FGF21) is closely related to various metabolic and cardiovascular disorders. However, the direct targets and mechanisms linking FGF21 to blood pressure control and hypertension are still elusive. Here we demonstrated a novel regulatory function of FGF21 in the baroreflex afferent pathway (the nucleus tractus solitarii, NTS; nodose ganglion, NG). As the critical co-receptor of FGF21, β-klotho (klb) significantly expressed on the NTS and NG. Furthermore, we evaluated the beneficial effects of chronic intraperitoneal infusion of recombinant human FGF21 (rhFGF21) on the dysregulated systolic blood pressure, cardiac parameters, baroreflex sensitivity (BRS) and hyperinsulinemia in the high fructose-drinking (HFD) rats. The BRS up-regulation is associated with Akt-eNOS-NO signaling activation in the NTS and NG induced by acute intravenous rhFGF21 administration in HFD and control rats. Moreover, the expressions of FGF21 receptors were aberrantly down-regulated in HFD rats. In addition, the up-regulated peroxisome proliferator-activated receptor-γ and -α (PPAR-γ/-α) in the NTS and NG in HFD rats were markedly reversed by chronic rhFGF21 infusion. Our study extends the work of the FGF21 actions on the neurocontrol of blood pressure regulations through baroreflex afferent pathway in HFD rats

Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases

Background: Human T cell Leukemia virus type 1 (HTLV-I) is etiologically linked to adult T cell leukemia/lymphoma (ATL) and an inflammatory neurodegenerative disease called HTLV-I-associated myelopathy or tropical spastic paraparesis (HAM/TSP). The exact genetic or epigenetic events and/or environmental factors that influence the development of ATL, or HAM/TSP diseases are largely unknown. The tumor suppressor gene, Fragile Histidine Triad Diadenosine Triphosphatase (FHIT), is frequently lost in cancer through epigenetic modifications and/or deletion. FHIT is a tumor suppressor acting as genome caretaker by regulating cellular DNA repair. Indeed, FHIT loss leads to replicative stress and accumulation of double DNA strand breaks. Therefore, loss of FHIT expression plays a key role in cellular transformation. Methods: Here, we studied over 400 samples from HTLV-I-infected individuals with ATL, TSP/HAM, or asymptomatic carriers (AC) for FHIT loss and expression. We examined the epigenetic status of FHIT through methylation specific PCR and bisulfite sequencing; and correlated these results to FHIT expression in patient samples. Results: We found that epigenetic alteration of FHIT is specifically found in chronic and acute ATL but is absent in asymptomatic HTLV-I carriers and TSP/HAM patients' samples. Furthermore, the extent of FHIT methylation in ATL patients was quantitatively comparable in virus-infected and virus non-infected cells. We also found that longitudinal HTLV-I carriers that progressed to smoldering ATL and descendants of ATL patients harbor FHIT methylation. Conclusions: These results suggest that germinal epigenetic mutation of FHIT represents a preexisting mark predisposing to the development of ATL diseases. These findings have important clinical implications as patients with acute ATL are rarely cured. Our study suggests an alternative strategy to the current "wait and see approach" in that early screening of HTLV-I-infected individuals for germinal epimutation of FHIT and early treatment may offer significant clinical benefits

Genome-Wide and Differential Proteomic Analysis of Hepatitis B Virus and Aflatoxin B1 Related Hepatocellular Carcinoma in Guangxi, China

Both hepatitis B virus (HBV) and aflatoxin B1 (AFB1) exposure can cause liver damage as well as increase the probability of hepatocellular carcinoma (HCC). To investigate the underlying genetic changes that may influence development of HCC associated with HBV infection and AFB1 exposure, HCC patients were subdivided into 4 groups depending upon HBV and AFB1 exposure status: (HBV(+)/AFB1(+), HBV(+)/AFB1(-), HBV(-)/AFB1(+), HBV(-)/AFB1(-)). Genetic abnormalities and protein expression profiles were analyzed by array-based comparative genomic hybridization and isobaric tagging for quantitation. A total of 573 chromosomal aberrations (CNAs) including 184 increased and 389 decreased were detected in our study population. Twenty-five recurrently altered regions (RARs; chromosomal alterations observed in ≥10 patients) in chromosomes were identified. Loss of 4q13.3-q35.2, 13q12.1-q21.2 and gain of 7q11.2-q35 were observed with a higher frequency in the HBV(+)/AFB1(+), HBV(+)/AFB1(-) and HBV(-)/AFB1(+) groups compared to the HBV(-)/AFB(-) group. Loss of 8p12-p23.2 was associated with high TNM stage tumors (P = 0.038) and was an unfavorable prognostic factor for tumor-free survival (P=0.045). A total of 133 differentially expressed proteins were identified in iTRAQ proteomics analysis, 69 (51.8%) of which mapped within identified RARs. The most common biological processes affected by HBV and AFB1 status in HCC tumorigenesis were detoxification and drug metabolism pathways, antigen processing and anti-apoptosis pathways. Expression of AKR1B10 was increased significantly in the HBV(+)/AFB1(+) and HBV(-)/AFB1(+) groups. A significant correlation between the expression of AKR1B10 mRNA and protein levels as well as AKR1B10 copy number was observed, which suggest that AKR1B10 may play a role in AFB1-related hepatocarcinogenesis. In summary, a number of genetic and gene expression alterations were found to be associated with HBV and AFB1- related HCC. The possible synergistic effects of HBV and AFB1 in hepatocarcinogenesis warrant further investigations